Author Archives: admin


Stem Cell’s in Sarasota by Regenerative clinic for Meniscus Damage. – Video

05-11-2011 09:35 http://www.GeckoJointandSpine.com Repair Meniscus injury with PRP. Platelet-rich plasma (PRP) is generically defined as an increase (above baseline) in the concentration of platelets and their associated growth factors. While the clinical benefits of PRP in enhancing the healing of musculoskeletal tissues are only beginning to be explored, the substantial amount of basic science data supporting the role of growth factors in enhancing cell migration, cell proliferation, and matrix synthesis has provided a compelling rationale for use of PRP in the treatment and repair of various connective tissue structures. In Sarasota florida now. I have asked a group of leading orthopedic surgeons who have utilized PRP in their respective practices to share their insight and experience regarding the potential role of PRP in enhancing connective tissue repair.

Read the original:
Stem Cell's in Sarasota by Regenerative clinic for Meniscus Damage. - Video

Oxford, Harvard scientists lead data-sharing effort

Public
release date: 29-Jan-2012
[ |
E-mail
| Share

]

Contact: Adi Himpson
adi.himpson@oerc.ox.ac.uk
44-186-561-0620
Harvard
University

Led by researchers at University of Oxford (UK) and the Harvard
Stem Cell Institute (HSCI) at Harvard University, (USA), more
than 50 collaborators at over 30 scientific organizations
around the globe have agreed on a common standard that will
make possible the consistent description of enormous and
radically different databases compiled in fields ranging from
genetics to stem cell science, to environmental studies.

The new standard provides a way for scientists in widely
disparate fields to co-ordinate each other's findings by
allowing behind-the-scenes combination of the mountains of data
produced by modern, technology driven science.

"We are now working together to provide the means to manage
enormous quantities of otherwise incompatible data, ranging
from the biomedical to the environmental," says Susanna-Assunta
Sansone, Ph.D, Team Leader of the project at the University of
Oxford's Oxford e-Research Centre.

This standard-compliant data sharing effort and the
establishment of its on-line presence, the ISA Commons ?
http://www.isacommons.org, is
described in a Commentary published today in the journal
Nature Genetics. The commentary is signed by all the
collaborators.

"An example of how this works at the Harvard Stem Cell
Institute is that we can now find a relationship between
experiments involving normal blood stem cells in fish and
cancers in children", says Winston Hide, director of HSCI's new
Center for Stem Cell Bioinformatics, and an associate Professor
of Bioinformatics at the Harvard School of Public Health.

ISA Commons is also being used at Harvard Medical School (HMS)
by the HMS LINCS
(Library of Integrated Network-based Cellular Signatures)
project, led by Professors Peter Sorger and Timothy
Mitchison.

It was necessary to establish common data standards, say the
commentary's authors, because of the tsunami of data and
technologies washing over the sciences. "There are hundreds of
new technologies coming along but also many ways to describe
the information produced" said Sansone, noting that "we can
take a jigsaw puzzle of different sciences and now fit the many
pieces together to form a complete picture".

"One of the things that I find most empowering about this
effort is that now small research groups can begin to store
laboratory data using this framework, complying with community
standards, without their own dedicated bioinformatics support.
It is a bit like Facebook allowing everyone to create their own
website pages - suddenly you don't need to be an expert in
computing to get your data out to the rest of the world", says
Dr. Jules Griffin, of the University of Cambridge.

"What we like about it is its unifying nature across different
bioscience fields and institutions", says Dr. Christoph
Steinbeck, European Molecular Biology Laboratory, The European
Bioinformatics Institute.

And "it also has the potential to work for large centers too",
says Scott Edmunds, editor of the journal published by
open-access publisher BioMedCentral and BGI Shenzhen
(previously known as the Beijing Genomics Institute) the
world's largest genomics institute, "We are working with this
framework to help harmonizing and presenting may large-data
types as possible in a common standardized and usable form,
publishing it in the associated GigaScience journal."

###

The work was funded, by among others, the Harvard Stem Cell
Institute, the U.S. National Institutes of Health, and the UK's
Biotechnology and Biological Sciences Research Council (BBSRC)
and Natural Environment Research Council (NERC).

The Oxford e-Research
Centre works across the University of Oxford, and at
national and international level, to accelerate research
through development of innovative computational and information
technologies in multidisciplinary collaborations. The Harvard Stem Cell Institute
is a collaboration of more than 100 Harvard and
Harvard-affiliated scientists dedicated to using the power of
stem cell biology to advance basic understanding of human
development in order to develop treatments and cures for a host
of degenerative conditions and diseases.

B. D. Colen, Harvard Stem Cell Institute
bd_colen@harvard.edu
- 617-495-7821/617-413-1224

Adi Himpson, Oxford e-Research Centre, University of Oxford
adi.himpson@oerc.ox.ac.uk
- +44 1865 610620

[ |
E-mail
| Share

]

 


AAAS and EurekAlert! are not responsible for the accuracy
of news releases posted to EurekAlert! by contributing
institutions or for the use of any information through the
EurekAlert! system.

More:
Oxford, Harvard scientists lead data-sharing effort

First True MS Flare-up Since Having Stem Cell Treatment – Video

16-01-2010 13:37 I have Secondary Progressive Multiple Sclerosis or MS and had an extremely successful stem cell treatment over a year ago. The stem cell treatment is safe and follows US medical standards of care, but is not yet FDA approved. It gave me my life back, but it is a treatment and not a cure. I am just recovering from my first MS flare-up and have no doubt that I will recoup and be healthy once again very soon. iLoveMyNewStemCells and all they have done and all they continue to do and all the potential they have for so many in the future.

See original here:
First True MS Flare-up Since Having Stem Cell Treatment - Video

Lecture by stem cell researcher tomorrow

Celebrated adult stem cell researcher Shinya Yamanaka will
deliver a lecture, ‘New era of medicine with iPS cells', here
on Monday as part of a three-city lecture series. Prof.
Yamanaka's scientific breakthrough was the creation of
embryonic-like stem cells from adult skin cells.

The lecture by this Japanese physician is the third edition of
The Cell Press-TNQ India Distinguished Lectureship Series. He
will also deliver it in Chennai on February 1 and New Delhi on
February 3. The lecture series is co-sponsored by Cell Press
and TNQ Books and Journals.

Quantum leap

The stated goal of Prof. Yamanaka's laboratory has been to
generate pluripotent stem cells from human somatic cells. The
ability to re-programme adult cells back into an earlier,
undifferentiated state has helped to reshape the ethical debate
over stem cell research by providing an approach to obtain
pluripotent stem cells that need not be harvested from an
embryo.

Prof. Yamanaka, who was awarded the Albert Lasker Prize in 2009
and the Wolf Prize in 2011, is the director of the Centre for
iPS Cell Research and Application and professor at the
Institute for Frontier Medical Sciences at Kyoto University. He
is also a senior investigator at the UCSF-affiliated J. David
Gladstone Institutes and a professor of Anatomy at the
University of California in San Francisco.

Previous lectures

The inaugural speaker of the lecture series was American
biologist David Baltimore, who won the 1975 Nobel. The second
speaker was Australia-born American biological researcher
Elizabeth Blackburn, awarded the 2009 Nobel.

The lecture in Bangalore will commence at 4.30 p.m. at J.N.
Tata Auditorium, National Science Seminar Complex, Indian
Institute of Science, C.V. Raman Road.

Read more from the original source:
Lecture by stem cell researcher tomorrow

Vet-Stem Announces Milestone of 8,000 Animals Treated With Vet-Stem Cell Therapy

POWAY, CA--(Marketwire -01/27/12)- Vet-Stem, Inc. today
announced that over 8,000 animals have now been treated with
Vet-Stem cell
therapy
.

Vet-Stem
began providing stem cells to veterinarians in 2004
and has now provided stem cells for the treatment of over
8,000 animals. Vet-Stem was the first company to introduce
rapid turnaround stem cell services in the US. After
providing stem cells for thousands of horses, Vet-Stem
pioneered stem
cell therapy
in dogs and cats and is now the world
leader in Regenerative Veterinary Medicine™. The rapid
adoption of stem cell therapy by equine veterinarians and
horse owners provided a springboard for use in small animal
veterinary medicine.

Greater than 75% of horses treated with Vet-Stem cell therapy
for tendon and ligament injuries are able to return to their
previous level of performance. Dog owners report that greater
than 80% of dogs treated with Vet-Stem cell therapy have an
improved quality of life.

"We are proud that so many dog, horse, and cat owners as well
as veterinarians have placed their trust in Vet-Stem cell
therapy. We feel a great sense of accomplishment knowing that
there are now over 8,000 horse and pet owners who have
experienced the benefit of stem cell technology. This
practical and beneficial application of technology puts stem
cell therapy into the present day instead of a future
theoretical concept," said Bob Harman, DVM, MPVM, Founder and
CEO of Vet-Stem.

Vet-Stem is now working with small animal veterinarians to
develop other life-saving uses for stem cell therapy for
injuries and diseases that currently have few treatment
options.

More information about Vet-Stem can be found at http://www.Vet-Stem.com[1]

About Vet-Stem, Inc.:
Vet-Stem, Inc. was formed in
2002 to bring regenerative medicine to the veterinary
profession. This privately held company delivers stem cell
and related services and products to veterinarians to treat
diseases in dogs, cats and horses. These technologies utilize
the natural healing properties inherent in all animals to
reduce pain and improve the quality of life of our animal
companions. Published studies have confirmed that
adipose-derived stem cells can dramatically improve the
healing of injuries and diseases that have had very few
treatment options in the past.

Vet-Stem holds the exclusive worldwide veterinary rights to
the Artecel (University of Pittsburgh) and University of
California adipose stem cell patent portfolio of over 55
issued patents.

References

  1. ^ http://www.Vet-Stem.com
    (us.lrd.yahoo.com)

View original post here:
Vet-Stem Announces Milestone of 8,000 Animals Treated With Vet-Stem Cell Therapy

Umbilical Stem Cell Breakthrough! (Brainstorm Ep41) – Video

23-01-2012 09:18 Website qdragon.info Shirts and Stuff http://www.zazzle.com My twitter twitter.com Like Brainstorm on Facebook http://www.facebook.com Medical News tinyurl.com Evolution News tinyurl.com Molecular Biology News tinyurl.com Hosted by http://www.youtube.com Contributors http://www.youtube.com http://www.youtube.com

See original here:
Umbilical Stem Cell Breakthrough! (Brainstorm Ep41) - Video